Back to search
FDAFDA · Food and drugs·Recall number D-0116-2022

GOAL-GLUTAMINE 75MG/ORNITHINE 75MG/ARGININE 150MG/LYSINE 150MG+LIDOCAINE 10MG/ML 75MG/75MG/150MG/150MG/10MG/ML INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247

Published November 17, 2021 · Recall initiated: October 12, 2021

Summary

FDA records drug Class II recall D-0116-2022, published November 17, 2021 and initiated October 12, 2021. Recalling firm: Vita Pharmacy, LLC dba Talon Compounding Pharmacy; Status: Terminated; Reported quantity: 5 vials; Lot: Lot: 05062021:44 BUD: 11/02/2021; 08192021:87 BUD: 02/15/2022. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of assurance of sterility

What to do

Voluntary: Firm initiated · Telephone

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Vita Pharmacy, LLC dba Talon Compounding Pharmacy
Distributor
United States including Washington, D.C. and Puerto Rico
Lot
Lot: 05062021:44 BUD: 11/02/2021; 08192021:87 BUD: 02/15/2022
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was GOAL-GLUTAMINE 75MG/ORNITHINE 75MG/ARGININE 150MG/LYSINE 150MG+LIDOCAINE 10MG/ML 75MG/75MG/150MG/150MG/10MG/ML INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247 recalled?

Yes. FDA published recall D-0116-2022 on November 17, 2021. Reported hazard: Lack of assurance of sterility

What should I do if I have this product?

Voluntary: Firm initiated · Telephone